These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 22361172)
1. REGγ is associated with multiple oncogenic pathways in human cancers. He J; Cui L; Zeng Y; Wang G; Zhou P; Yang Y; Ji L; Zhao Y; Chen J; Wang Z; Shi T; Zhang P; Chen R; Li X BMC Cancer; 2012 Feb; 12():75. PubMed ID: 22361172 [TBL] [Abstract][Full Text] [Related]
2. ATP citrate lyase promotes the progression of hepatocellular carcinoma by activating the REGγ-proteasome pathway. Cai Q; Zhu H; Dai Y; Zhou Q; Zhang Q; Zhu Q Mol Carcinog; 2024 Oct; 63(10):1874-1891. PubMed ID: 38888205 [TBL] [Abstract][Full Text] [Related]
3. [REGgamma promotes malignant behaviors of lung cancer cells]. Qin Q; Guo FC; Luo ST; Li XY; Liu XK; Wang YS Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Mar; 45(2):304-8. PubMed ID: 24749363 [TBL] [Abstract][Full Text] [Related]
4. REGγ Controls Hippo Signaling and Reciprocal NF-κB-YAP Regulation to Promote Colon Cancer. Wang Q; Gao X; Yu T; Yuan L; Dai J; Wang W; Chen G; Jiao C; Zhou W; Huang Q; Cui L; Zhang P; Moses RE; Yang J; Chen F; Fu J; Xiao J; Li L; Dang Y; Li X Clin Cancer Res; 2018 Apr; 24(8):2015-2025. PubMed ID: 29437787 [No Abstract] [Full Text] [Related]
5. Comparative analysis of REG{gamma} expression in mouse and human tissues. Yu G; Zhao Y; He J; Lonard DM; Mao CA; Wang G; Li M; Li X J Mol Cell Biol; 2010 Aug; 2(4):192-8. PubMed ID: 20494959 [TBL] [Abstract][Full Text] [Related]
6. Differential regulation of the REGγ-proteasome pathway by p53/TGF-β signalling and mutant p53 in cancer cells. Ali A; Wang Z; Fu J; Ji L; Liu J; Li L; Wang H; Chen J; Caulin C; Myers JN; Zhang P; Xiao J; Zhang B; Li X Nat Commun; 2013; 4():2667. PubMed ID: 24157709 [TBL] [Abstract][Full Text] [Related]
7. Regulation of c-Myc protein stability by proteasome activator REGγ. Li S; Jiang C; Pan J; Wang X; Jin J; Zhao L; Pan W; Liao G; Cai X; Li X; Xiao J; Jiang J; Wang P Cell Death Differ; 2015 Jun; 22(6):1000-11. PubMed ID: 25412630 [TBL] [Abstract][Full Text] [Related]
8. Reciprocal REGγ-mTORC1 regulation promotes glycolytic metabolism in hepatocellular carcinoma. Yao L; Xuan Y; Zhang H; Yang B; Ma X; Wang T; Meng T; Sun W; Wei H; Ma X; Moses R; Xiao J; Zhang P; Ge C; Li J; Li L; Li X; Li J; Zhang B Oncogene; 2021 Jan; 40(3):677-692. PubMed ID: 33230243 [TBL] [Abstract][Full Text] [Related]
9. REGγ ablation impedes dedifferentiation of anaplastic thyroid carcinoma and accentuates radio-therapeutic response by regulating the Smad7-TGF-β pathway. Jiao C; Li L; Zhang P; Zhang L; Li K; Fang R; Yuan L; Shi K; Pan L; Guo Q; Gao X; Chen G; Xu S; Wang Q; Zuo D; Wu W; Qiao S; Wang X; Moses R; Xiao J; Li L; Dang Y; Li X Cell Death Differ; 2020 Feb; 27(2):497-508. PubMed ID: 31243343 [TBL] [Abstract][Full Text] [Related]
10. Expression of proteasome activator REGγ in human laryngeal carcinoma and associations with tumor suppressor proteins. Li LP; Cheng WB; Li H; Li W; Yang H; Wen DH; Tang YD Asian Pac J Cancer Prev; 2012; 13(6):2699-703. PubMed ID: 22938444 [TBL] [Abstract][Full Text] [Related]
11. REG gamma: a potential marker in breast cancer and effect on cell cycle and proliferation of breast cancer cell. Wang X; Tu S; Tan J; Tian T; Ran L; Rodier JF; Ren G Med Oncol; 2011 Mar; 28(1):31-41. PubMed ID: 20467919 [TBL] [Abstract][Full Text] [Related]
12. Mutant p53 (p53-R248Q) functions as an oncogene in promoting endometrial cancer by up-regulating REGγ. Wang H; Bao W; Jiang F; Che Q; Chen Z; Wang F; Tong H; Dai C; He X; Liao Y; Liu B; Sun J; Wan X Cancer Lett; 2015 May; 360(2):269-79. PubMed ID: 25697482 [TBL] [Abstract][Full Text] [Related]
13. REGgamma, a proteasome activator and beyond? Mao I; Liu J; Li X; Luo H Cell Mol Life Sci; 2008 Dec; 65(24):3971-80. PubMed ID: 18679578 [TBL] [Abstract][Full Text] [Related]
14. REGγ Is Associated with Lymph Node Metastasis and T-Stage in Papillary Thyroid Carcinoma. Qi L; He W Med Sci Monit; 2018 Mar; 24():1373-1378. PubMed ID: 29509725 [TBL] [Abstract][Full Text] [Related]
15. Ubiquitin- and ATP-independent proteolytic turnover of p21 by the REGgamma-proteasome pathway. Li X; Amazit L; Long W; Lonard DM; Monaco JJ; O'Malley BW Mol Cell; 2007 Jun; 26(6):831-42. PubMed ID: 17588518 [TBL] [Abstract][Full Text] [Related]
16. REGγ regulates ERα degradation via ubiquitin-proteasome pathway in breast cancer. Chai F; Liang Y; Bi J; Chen L; Zhang F; Cui Y; Jiang J Biochem Biophys Res Commun; 2015 Jan; 456(1):534-40. PubMed ID: 25490392 [TBL] [Abstract][Full Text] [Related]
17. REGγ deficiency suppresses tumor progression via stabilizing CK1ε in renal cell carcinoma. Chen S; Wang Q; Wang L; Chen H; Gao X; Gong D; Ma J; Kubra S; Yao X; Li X; Li L; Zhai W; Zheng J Cell Death Dis; 2018 May; 9(6):627. PubMed ID: 29795381 [TBL] [Abstract][Full Text] [Related]
18. REGγ potentiates TGF-β/Smad signal dependent epithelial-mesenchymal transition in thyroid cancer cells. Bhatti MZ; Pan L; Wang T; Shi P; Li L Cell Signal; 2019 Dec; 64():109412. PubMed ID: 31491459 [TBL] [Abstract][Full Text] [Related]
19. Oxidative challenge enhances REGγ-proteasome-dependent protein degradation. Zhang Y; Liu S; Zuo Q; Wu L; Ji L; Zhai W; Xiao J; Chen J; Li X Free Radic Biol Med; 2015 May; 82():42-9. PubMed ID: 25656993 [TBL] [Abstract][Full Text] [Related]
20. Silencing CDR1as enhances the sensitivity of breast cancer cells to drug resistance by acting as a miR-7 sponge to down-regulate REGγ. Yang W; Yang X; Wang X; Gu J; Zhou D; Wang Y; Yin B; Guo J; Zhou M J Cell Mol Med; 2019 Aug; 23(8):4921-4932. PubMed ID: 31245927 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]